Unique TeloVac vaccine does not just protect against cancer, but actually it treats
The next two years in the arsenal of physicians may receive universal vaccine TeloVac, which will change the usual understanding of the treatment of cancer, writes The Daily Mail. The vaccine production GemVax Korean company is a new type of drugs that use the bodys natural defenses to fight the disease. TeloVac already been successfully tested on several hundreds of Britons with pancreatic cancer.
Scientists hope that the vaccine will be as effective in the struggle with other types of cancer, including melanoma, lung, liver, breast and prostate. So, the main difference between the new vaccine is: traditional vaccines used in order to prevent infection or the development of the disease, but the new version just treats cancer by activating the immune system.
As a result, the immune system attacks and destroys the enzyme telomerase, which is found in large quantities in many cancer cells. It is this enzyme makes cancer cells immortal, facilitating their growth and spread. With the introduction of the vaccine healthy cells remain intact due to low enzyme. This allows you to avoid side effects such as hair loss, nausea.
According to the testimony of volunteers who have experienced the vaccine, TeloVac gave them additional 1-2 years of life. But the earlier survey finding suggests that the introduction of the drug, even at a late stage cancer patient gives an average 3 months of life.